![A p85α-osteopontin axis couples the receptor ICOS to sustained Bcl-6 expression by follicular helper and regulatory T cells | Nature Immunology A p85α-osteopontin axis couples the receptor ICOS to sustained Bcl-6 expression by follicular helper and regulatory T cells | Nature Immunology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fni.3050/MediaObjects/41590_2015_Article_BFni3050_Fig1_HTML.jpg)
A p85α-osteopontin axis couples the receptor ICOS to sustained Bcl-6 expression by follicular helper and regulatory T cells | Nature Immunology
![Lineage-specific functions of Bcl-6 in immunity and inflammation are mediated by distinct biochemical mechanisms | Nature Immunology Lineage-specific functions of Bcl-6 in immunity and inflammation are mediated by distinct biochemical mechanisms | Nature Immunology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fni.2543/MediaObjects/41590_2013_Article_BFni2543_Fig1_HTML.jpg)
Lineage-specific functions of Bcl-6 in immunity and inflammation are mediated by distinct biochemical mechanisms | Nature Immunology
![Bioengineering | Free Full-Text | Lymphatic Tissue Bioengineering for the Treatment of Postsurgical Lymphedema Bioengineering | Free Full-Text | Lymphatic Tissue Bioengineering for the Treatment of Postsurgical Lymphedema](https://pub.mdpi-res.com/bioengineering/bioengineering-09-00162/article_deploy/html/images/bioengineering-09-00162-g001.png?1649238396)
Bioengineering | Free Full-Text | Lymphatic Tissue Bioengineering for the Treatment of Postsurgical Lymphedema
![Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma | Nature Medicine Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-022-02178-3/MediaObjects/41591_2022_2178_Fig1_HTML.png)
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma | Nature Medicine
![Changes in peaks between conditions. (a) Detected m6A(m) changes in... | Download Scientific Diagram Changes in peaks between conditions. (a) Detected m6A(m) changes in... | Download Scientific Diagram](https://www.researchgate.net/publication/340788803/figure/fig4/AS:959607425990660@1605799647423/Changes-in-peaks-between-conditions-a-Detected-m6Am-changes-in-thirteen-published_Q320.jpg)
Changes in peaks between conditions. (a) Detected m6A(m) changes in... | Download Scientific Diagram
![Frontiers | A Boolean-based machine learning framework identifies predictive biomarkers of HSP90-targeted therapy response in prostate cancer Frontiers | A Boolean-based machine learning framework identifies predictive biomarkers of HSP90-targeted therapy response in prostate cancer](https://www.frontiersin.org/files/Articles/1094321/fmolb-10-1094321-HTML/image_m/fmolb-10-1094321-g001.jpg)
Frontiers | A Boolean-based machine learning framework identifies predictive biomarkers of HSP90-targeted therapy response in prostate cancer
![Cancers | Free Full-Text | Artificial Intelligence Predicted Overall Survival and Classified Mature B-Cell Neoplasms Based on Immuno-Oncology and Immune Checkpoint Panels Cancers | Free Full-Text | Artificial Intelligence Predicted Overall Survival and Classified Mature B-Cell Neoplasms Based on Immuno-Oncology and Immune Checkpoint Panels](https://pub.mdpi-res.com/cancers/cancers-14-05318/article_deploy/html/images/cancers-14-05318-g009b.png?1667316444)
Cancers | Free Full-Text | Artificial Intelligence Predicted Overall Survival and Classified Mature B-Cell Neoplasms Based on Immuno-Oncology and Immune Checkpoint Panels
![MEF2B mutations lead to deregulated expression of the oncogene BCL6 in diffuse large B cell lymphoma | Nature Immunology MEF2B mutations lead to deregulated expression of the oncogene BCL6 in diffuse large B cell lymphoma | Nature Immunology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fni.2688/MediaObjects/41590_2013_Article_BFni2688_Fig1_HTML.jpg)
MEF2B mutations lead to deregulated expression of the oncogene BCL6 in diffuse large B cell lymphoma | Nature Immunology
![IJMS | Free Full-Text | Uncovering Oncogenic Mechanisms of Tumor Suppressor Genes in Breast Cancer Multi-Omics Data IJMS | Free Full-Text | Uncovering Oncogenic Mechanisms of Tumor Suppressor Genes in Breast Cancer Multi-Omics Data](https://www.mdpi.com/ijms/ijms-23-09624/article_deploy/html/images/ijms-23-09624-g001.png)